Physician profile
Matthew Smiley
NPI 1437862489
$558.43
in general payments reported to CMS, 2019-2025
11 companies · $525 in 2025
The $525 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $33.21 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $558.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $261.06 | 2025 | Vumerity, Leqembi, Tysabri |
| Sk Life Science, INC. | $99.76 | 2025 | |
| Xeris Pharmaceuticals, INC. | $38.78 | 2025 | Keveyis |
| Ucb, INC. | $30.04 | 2025 | Rystiggo, Briviact |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $27.64 | 2024-2025 | Lifevest |
| Lilly USA, LLC | $18.63 | 2025 | Kisunla |
| Merz Pharmaceuticals, LLC | $18.21 | 2025 | Xeomin, Inbrija |
| Pfizer INC. | $17.74 | 2025 | |
| Abbvie INC. | $17.16 | 2024 | |
| Emd Serono, INC. | $15.58 | 2025 | |
| Novartis Pharmaceuticals Corporation | $13.83 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Smiley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.